| Automation in the clinical laboratory: integration of several analytical and intralaboratory pre- and post-analytical systems | Ozturk NURİNNİSA, Nurcan KİLİC-BAYGUTALP, Bakan EBUBEKİR | 1–13 |
| Flow cytometric detection of endothelial progenitor cells (EPC) in acute coronary syndrome | Mesude FALAY, Server AKTAŞ | 15–21 |
| Evaluation of prolidase activity in uremic bone disease | Doğan YÜCEL, Murat DURANAY, Elmas ÖĞÜŞ, Arzu KÖSEM | 23–29 |
| The independent relationship between hemoglobin A1c and homeostasis model assessment of insulin resistance in non-diabetic subjects | Hulya YALCİN, Ayfer COLAK, Burak TOPRAK | 31–36 |
| Association of missense substitution of A49T and V89L in the SRD5A2 gene with prostate cancer in Turkish patients | Alev KURAL, Ayten LİVAOGLU, Ilker TİNAY, Levent TURKERİ, Tulay CEVLİK, Sadi Konuk RESEARCH, Sebnem Tekin NEİJMANN | 37–43 |
| Delays in reporting critical values from clinical laboratories to responsible healthcare staff | Oğuzhan ÖZCAN, Gökhan ÇAKIRCA, Zafer YÖNDEN, Sedat MOTOR | 45–50 |
| Re-determining the cut-off points of FIB-4 for patients monoinfected with chronic hepatitis B virus infection | Huseyin KAYADİBİ, Selvinaz OZKARA, Ugur DEMİRPEK, Bulent YASAR | 51–57 |
| Halk sağlığı laboratuvarında preanalitik hatalara yaklaşım | Esin AVCI, Süleyman DEMİR, Zeliha KANGAL, Nihan ÇEKEN, Dilek İREN EMEKLİ, Nergiz ZORBOZAN | 59–63 |
| Serum proPSA as a marker for reducing repeated prostate biopsy numbers | Ali AYYILDIZ, Erdal BENLİ, Abdullah ÇIRAKOĞLU, Tevfik NOYAN, Sema Nur AYYILDIZ, Cemal AYYILDIZ | 65–69 |
| NT-proBNP levels in β-thalassemia major patients without cardiac hemosiderosis | Erdal KURTOĞLU, Volkan KARAKUŞ, Ayşegül Uğur KURTOĞLU, Selen BOZKURT | 71–75 |
| Comparison of high sensitive and conventional troponin assays in diagnosis of acute myocardial infarction | Mehmet ERTÜRK, Ömer Faruk BAYCAN, Serkan YAZAN, Mehmet Rıfat YILDIRIM, Murat KOŞER, Begüm ÖZALP, İsmail BIYIK, Nilgün IŞIKSAÇAN, İbrahim Faruk AKTÜRK, Hüseyin KARAKURT |